Skip to main content
Caplight Logo









Symcel

Symcel

Private
StockholmHealthcare & Life Scienceshttps://symcel.com/

Last Round

Grant

Jun 23, 2026

Total Funding Raised

$4.47M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Symcel is a biotechnology company that develops and markets biocalorimetry-based analytical instrumentation for cell and microbial research, including rapid sterility testing and metabolic monitoring.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Medical Devices, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

biocalorimetryisothermal microcalorimetrymicrobial detectionsterility testingantimicrobial susceptibility testingASTmetabolic monitoringcell therapyATMPrapid microbiologylabel-free detectionbiotech equipmentlab automationreal-time kineticsRMM

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Symcel Comparables

Compare Symcel with similar companies based on industry and business-model similarity.

Symcel comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ridgeview Instruments AB
79%
Lonza Group
76%
Rapid Micro Biosystems
71%

Symcel Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 23, 2026
GrantOct 22, 2025
VC RoundMay 28, 2025
VC RoundMar 14, 2024
VC RoundMay 11, 2022
Grant
Nov 21, 2017

Key People

Founding team and executive leadership

Jesper Ericsson

CEO

Executive Team

Jessica Ramstedt

HR, CEO Support and Facility Management

Executive Team

Niklas Jakobsson

COO at Symcel

Executive Team

Symcel Investors

Notable investors and investment history

Symcel investors
InvestorRounds
CEPIGrant
Flerie InvestVC Round
Flerie ABVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 88% MoM, reaching 1.6K.

  • Jun 23, 2026

    Received grant funding from CEPI.

Symcel Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Symcel Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Symcel's valuation, stock price, and market status.

Firmographic Details

HeadquartersStockholm
Employee Range52
Year Founded2004
Last FundingJun 23, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?